JPWO2022018729A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022018729A5
JPWO2022018729A5 JP2023503444A JP2023503444A JPWO2022018729A5 JP WO2022018729 A5 JPWO2022018729 A5 JP WO2022018729A5 JP 2023503444 A JP2023503444 A JP 2023503444A JP 2023503444 A JP2023503444 A JP 2023503444A JP WO2022018729 A5 JPWO2022018729 A5 JP WO2022018729A5
Authority
JP
Japan
Prior art keywords
stem cells
mesenchymal stem
ntfs
mscs
exo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023503444A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023534524A (ja
JP2023534524A5 (https=
JP7691488B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2021/050885 external-priority patent/WO2022018729A1/en
Publication of JP2023534524A publication Critical patent/JP2023534524A/ja
Publication of JPWO2022018729A5 publication Critical patent/JPWO2022018729A5/ja
Publication of JP2023534524A5 publication Critical patent/JP2023534524A5/ja
Priority to JP2025089972A priority Critical patent/JP2025128209A/ja
Application granted granted Critical
Publication of JP7691488B2 publication Critical patent/JP7691488B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023503444A 2020-07-20 2021-07-20 肺疾患を治療するための方法及び組成物 Active JP7691488B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025089972A JP2025128209A (ja) 2020-07-20 2025-05-29 肺疾患を治療するための方法及び組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063053780P 2020-07-20 2020-07-20
US63/053,780 2020-07-20
US202163133350P 2021-01-03 2021-01-03
US63/133,350 2021-01-03
PCT/IL2021/050885 WO2022018729A1 (en) 2020-07-20 2021-07-20 Methods and compositions for treating lung conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025089972A Division JP2025128209A (ja) 2020-07-20 2025-05-29 肺疾患を治療するための方法及び組成物

Publications (4)

Publication Number Publication Date
JP2023534524A JP2023534524A (ja) 2023-08-09
JPWO2022018729A5 true JPWO2022018729A5 (https=) 2025-01-24
JP2023534524A5 JP2023534524A5 (https=) 2025-01-24
JP7691488B2 JP7691488B2 (ja) 2025-06-11

Family

ID=77265158

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023503444A Active JP7691488B2 (ja) 2020-07-20 2021-07-20 肺疾患を治療するための方法及び組成物
JP2025089972A Pending JP2025128209A (ja) 2020-07-20 2025-05-29 肺疾患を治療するための方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025089972A Pending JP2025128209A (ja) 2020-07-20 2025-05-29 肺疾患を治療するための方法及び組成物

Country Status (7)

Country Link
US (1) US20230310507A1 (https=)
EP (1) EP4181935A1 (https=)
JP (2) JP7691488B2 (https=)
AU (1) AU2021313472B2 (https=)
CA (1) CA3189818A1 (https=)
IL (1) IL299997A (https=)
WO (1) WO2022018729A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021526556A (ja) 2018-05-30 2021-10-07 ダイレクト バイオロジクス エルエルシー 成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞(msc)の調製物を含む助剤、ならびにその使用方法
BR112021015549A2 (pt) 2019-02-07 2021-10-26 Direct Biologics Llc Método para tratar osteoartrite com uma combinação de exossomos de células tronco mesenquimais, células tronco mesenquimais sinoviais e andaimes
CA3146433A1 (en) 2019-07-18 2021-01-21 Direct Biologics Llc Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use
CN113384597A (zh) * 2020-03-13 2021-09-14 西比曼生物科技(上海)有限公司 含人体细胞衍生的细胞膜外囊泡的雾化吸入制剂、制法及其应用
US12590310B2 (en) 2020-04-22 2026-03-31 Direct Biologics, Llc Methods and compositions for treating inflammatory conditions associated with infectious disease
EP4252761A4 (en) * 2020-11-26 2024-06-05 Samsung Life Public Welfare Foundation COMPOSITION FOR THE TREATMENT OF INFECTIOUS DISEASES, COMPRISING EXOSOMES DERIVED FROM THROMBIN-PROCESSED STEM CELLS
KR20240003167A (ko) * 2022-06-30 2024-01-08 주식회사 지씨셀 편도유래줄기세포를 유효성분으로 포함하는 감염성 폐 질환의 예방 또는 치료용 조성물
WO2024236603A1 (en) * 2023-05-18 2024-11-21 Khorakiwala Zahabiya Growth factor concentrate composition
CN116897887A (zh) * 2023-07-31 2023-10-20 湖南中医药大学 一种病毒性哮喘动物模型的构建方法
US12502407B2 (en) 2024-04-25 2025-12-23 Direct Biologics, Llc Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080095749A1 (en) 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CA2829586C (en) 2011-03-11 2021-03-02 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
DK2880151T3 (da) * 2012-08-06 2020-08-17 Brainstorm Cell Therapeutics Ltd Fremgangsmåder til frembringelse af mesenkymale stemceller, som udskiller neurotrofiske faktorer
ES2909752T3 (es) * 2013-08-01 2022-05-10 Swedish Stromabio Ab MSC en el tratamiento de enfermedades pulmonares inflamatorias
KR101843634B1 (ko) 2016-04-15 2018-03-30 사회복지법인 삼성생명공익재단 트롬빈 처리 줄기세포에서 유래된 엑소좀을 포함하는 만성폐질환 치료용 조성물
CA3072562A1 (en) * 2017-08-15 2019-02-21 Children's Medical Center Corporation Purified mesenchymal stem cell exosomes and uses thereof
GB2568255A (en) * 2017-11-08 2019-05-15 Evox Therapeutics Ltd Exosomes comprising RNA therapeutics
US12233092B2 (en) 2018-04-10 2025-02-25 Brainstorm Cell Therapeutics Ltd. MSC-NTF specific exosomes and use thereof
EP3813858B1 (en) * 2018-06-29 2023-11-01 North Carolina State University Therapeutic lung repair by inhalation of lung spheroid exosomes
BR112022017557A2 (pt) * 2020-03-05 2022-12-27 Mesoblast Int Sarl Método para tratar doenças pulmonares inflamatórias com o uso de células-tronco ou precursoras de linhagem mesenquimal
WO2021181399A1 (en) * 2020-03-12 2021-09-16 Exostem Biotec Ltd. Mesenchymal stromal cells and extracellular vesicles for treating viral infections, inflammation, and tissue fibrosis
CA3173216A1 (en) * 2020-04-03 2021-10-07 Silviu Itescu Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells
EP4132479A1 (en) * 2020-04-07 2023-02-15 Ramot at Tel-Aviv University Ltd. Cannabidiol-containing compositions and uses thereof

Similar Documents

Publication Publication Date Title
JP2026041749A5 (https=)
Zhu et al. Broad-spectrum antiviral agents
KR101571571B1 (ko) 황화 폴리사카라이드를 포함하는 항바이러스 조성물
Sommadossi et al. Uridine reverses the toxicity of 3'-azido-3'-deoxythymidine in normal human granulocyte-macrophage progenitor cells in vitro without impairment of antiretroviral activity
Sohag et al. Revisiting potential druggable targets against SARS‐CoV‐2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
CA2179627C (en) Mixtures of dideoxy-nucleosides and hydroxycarbamide for inhibiting retroviral spread
ES2343701T3 (es) Uso de carragenina para el tratamiento de infecciones por rinovirus.
Lai et al. Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus
JPWO2022018729A5 (https=)
JP2023076632A5 (https=)
Bonville et al. Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents
Alshaeri et al. A contemporary look at COVID-19 medications: available and potentially effective drugs
RU2012146542A (ru) Способ ингибирования репликации вич в клетках млекопитающих и у людей
Stephens et al. Significance of macrophage tropism of SIV in the macaque model of HIV disease
CN118615306A (zh) 一种抑制病毒感染的药物组合物及其应用
JPWO2021160881A5 (https=)
CN118434435A (zh) 用于治疗病毒感染的药物组合物
US20230030607A1 (en) Novel oxygen pulse therapy method for treating COVID19 and viral, bacterial, fungal or parasitic respiratory and other diseases
CN109700823A (zh) 泰利霉素在抗埃博拉病毒感染中的应用
JPWO2020056145A5 (https=)
WO2021181044A1 (fr) Composition comprenant du diltiazem pour traiter l'infection virale par les virus sars-cov-2
CN112675172A (zh) 一种二酮哌嗪类化合物在制备抗冠状病毒药物中的用途
Dhurvey et al. Two worst pandemics-Spanish Flu and COVID-19: a review
JP7705427B2 (ja) コロナウイルス感染抑制のための植物成分組成物及び生薬組成物
Parveen et al. Respiratory syncytial virus (RSV): prevention and antiviral therapeutic strategies